(QURE) Uniqure - Performance 150.5% in 12m
Compare QURE with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-52.65%
#75 in Group
Rel. Strength
98.74%
#101 in Universe
Total Return 12m
150.51%
#3 in Group
Total Return 5y
-79.65%
#86 in Group
P/E -
(?) Percentile in Group
P/E Forward 27.9
75th Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -37.54%
(?) Percentile in Group
12m Total Return: QURE (150.5%) vs XBI (-12.3%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
| BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
| NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
| ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: QURE vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for QURE
| Total Return (including Dividends) | QURE | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 46.88% | 11.81% | 13.81% |
| 3 Months | -10.19% | -13.61% | -6.30% |
| 12 Months | 150.51% | -12.29% | 10.65% |
| 5 Years | -79.65% | -24.89% | 107.77% |
| Trend Score (consistency of price movement) | QURE | XBI | S&P 500 |
| 1 Month | 59.7% | 72.9% | 83% |
| 3 Months | 1.30% | -83% | -75.3% |
| 12 Months | 75.7% | -51.6% | 50.1% |
| 5 Years | -88.0% | -53.9% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #11 | 31.4% | 29.1% |
| 3 Month | #72 | 3.96% | -4.15% |
| 12 Month | #4 | 186% | 126% |
| 5 Years | #86 | -72.9% | -90.2% |
FAQs
Does QURE Uniqure outperforms the market?
Yes,
over the last 12 months QURE made 150.51%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months QURE made -10.19%, while XBI made -13.61%.
Over the last 3 months QURE made -10.19%, while XBI made -13.61%.
Performance Comparison QURE vs Indeces and Sectors
QURE vs. Indices QURE is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -19.5% | 33.1% | 62.2% | 140% |
| US NASDAQ 100 | QQQ | -19.7% | 29.5% | 62.0% | 139% |
| US Dow Jones Industrial 30 | DIA | -19.9% | 36.9% | 62.5% | 143% |
| German DAX 40 | DAX | -19.5% | 31.9% | 35.9% | 125% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -21.7% | 35.1% | 61.4% | 143% |
| Hongkong Hang Seng | HSI | -22.7% | 27.0% | 53.8% | 137% |
| India NIFTY 50 | INDA | -14.6% | 42.0% | 61.8% | 151% |
| Brasil Bovespa | EWZ | -20.6% | 29.6% | 53.5% | 159% |
QURE vs. Sectors QURE is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -20.2% | 33.5% | 55.1% | 129% |
| Consumer Discretionary | XLY | -19.9% | 32.7% | 63.2% | 136% |
| Consumer Staples | XLP | -18.7% | 40.3% | 55.3% | 141% |
| Energy | XLE | -19.3% | 40.1% | 68.8% | 160% |
| Financial | XLF | -20.6% | 33.4% | 55.1% | 128% |
| Health Care | XLV | -16.5% | 46.0% | 67.2% | 155% |
| Industrial | XLI | -21.2% | 30.1% | 60.8% | 140% |
| Materials | XLB | -19.3% | 33.3% | 67.1% | 156% |
| Real Estate | XLRE | -18.2% | 35.3% | 61.4% | 135% |
| Technology | XLK | -20.6% | 25.7% | 65.1% | 143% |
| Utilities | XLU | -19.6% | 37.3% | 54.5% | 133% |
| Aerospace & Defense | XAR | -21.5% | 25.7% | 50.7% | 123% |
| Biotech | XBI | -12.9% | 35.1% | 82.3% | 163% |
| Homebuilder | XHB | -20.0% | 35.4% | 75.4% | 158% |
| Retail | XRT | -21.4% | 32.2% | 66.4% | 152% |